Van Eck Associates Corp Alnylam Pharmaceuticals, Inc. Transaction History

Van Eck Associates Corp

  • $77.4 Billion
  • Q1 2025

A detailed history of Van Eck Associates Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 64,144 shares of ALNY stock, worth $20.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
64,144
Previous 67,818 5.42%
Holding current value
$20.8 Million
Previous $16 Million 8.53%
% of portfolio
0.02%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$233.07 - $290.7 $856,299 - $1.07 Million
-3,674 Reduced 5.42%
64,144 $17.3 Million
Q4 2024

Jan 29, 2025
BUY
$232.27 - $300.43 $2.42 Million - $3.13 Million
10,419 Added 18.15%
67,818 $16 Million
Q3 2024

Oct 29, 2024
SELL
$233.81 - $287.01 $827,453 - $1.02 Million
-3,539 Reduced 5.81%
57,399 $16.9 Million
Q2 2024

Jul 31, 2024
BUY
$143.31 - $247.0 $432,079 - $744,705
3,015 Added 5.21%
60,938 $14.8 Million
Q1 2024

Apr 30, 2024
SELL
$146.51 - $198.2 $484,948 - $656,042
-3,310 Reduced 5.41%
57,923 $8.66 Million
Q4 2023

Feb 05, 2024
SELL
$151.41 - $196.57 $1.49 Million - $1.94 Million
-9,853 Reduced 13.86%
61,233 $11.7 Million
Q3 2023

Nov 08, 2023
SELL
$170.77 - $211.65 $1.18 Million - $1.46 Million
-6,882 Reduced 8.83%
71,086 $12.6 Million
Q2 2023

Aug 03, 2023
SELL
$185.01 - $212.05 $612,938 - $702,521
-3,313 Reduced 4.08%
77,968 $14.8 Million
Q1 2023

May 03, 2023
SELL
$182.66 - $235.53 $2.03 Million - $2.61 Million
-11,099 Reduced 12.01%
81,281 $16.3 Million
Q4 2022

Feb 08, 2023
BUY
$185.53 - $241.31 $4.17 Million - $5.43 Million
22,484 Added 32.17%
92,380 $22 Million
Q3 2022

Oct 27, 2022
SELL
$138.54 - $232.0 $5.48 Million - $9.17 Million
-39,546 Reduced 36.13%
69,896 $14 Million
Q2 2022

Aug 03, 2022
BUY
$120.42 - $169.29 $1.14 Million - $1.6 Million
9,436 Added 9.44%
109,442 $16 Million
Q1 2022

May 10, 2022
BUY
$127.18 - $173.91 $177,034 - $242,082
1,392 Added 1.41%
100,006 $16.3 Million
Q4 2021

Jan 26, 2022
BUY
$159.56 - $209.29 $943,478 - $1.24 Million
5,913 Added 6.38%
98,614 $16.7 Million
Q3 2021

Nov 03, 2021
SELL
$169.75 - $207.73 $4.74 Million - $5.8 Million
-27,921 Reduced 23.15%
92,701 $17.5 Million
Q2 2021

Aug 10, 2021
BUY
$128.63 - $176.89 $2.62 Million - $3.6 Million
20,368 Added 20.32%
120,622 $20.4 Million
Q1 2021

May 13, 2021
SELL
$126.83 - $175.69 $630,979 - $874,057
-4,975 Reduced 4.73%
100,254 $14.2 Million
Q4 2020

Feb 09, 2021
BUY
$122.97 - $147.0 $2.31 Million - $2.76 Million
18,790 Added 21.74%
105,229 $13.7 Million
Q3 2020

Nov 12, 2020
SELL
$121.19 - $165.49 $2.98 Million - $4.06 Million
-24,559 Reduced 22.13%
86,439 $12.6 Million
Q2 2020

Aug 10, 2020
BUY
$104.21 - $156.44 $2.5 Million - $3.75 Million
23,994 Added 27.58%
110,998 $16.4 Million
Q1 2020

May 12, 2020
SELL
$93.12 - $133.99 $2.6 Million - $3.74 Million
-27,922 Reduced 24.3%
87,004 $9.47 Million
Q4 2019

Feb 13, 2020
BUY
$74.51 - $124.23 $289,471 - $482,633
3,885 Added 3.5%
114,926 $13.2 Million
Q3 2019

Nov 08, 2019
BUY
$70.9 - $87.82 $467,372 - $578,909
6,592 Added 6.31%
111,041 $8.93 Million
Q2 2019

Aug 07, 2019
SELL
$65.86 - $92.79 $1.37 Million - $1.93 Million
-20,824 Reduced 16.62%
104,449 $7.58 Million
Q1 2019

May 13, 2019
BUY
$72.76 - $93.45 $671,429 - $862,356
9,228 Added 7.95%
125,273 $11.7 Million
Q4 2018

Feb 12, 2019
BUY
$62.67 - $88.33 $289,660 - $408,261
4,622 Added 4.15%
116,045 $8.46 Million
Q3 2018

Nov 13, 2018
BUY
$87.52 - $122.67 $2.91 Million - $4.08 Million
33,228 Added 42.49%
111,423 $9.75 Million
Q2 2018

Aug 13, 2018
BUY
$88.31 - $107.8 $966,994 - $1.18 Million
10,950 Added 16.28%
78,195 $7.7 Million
Q1 2018

May 11, 2018
SELL
$115.92 - $148.54 $2.26 Million - $2.89 Million
-19,454 Reduced 22.44%
67,245 $8.01 Million
Q4 2017

Feb 12, 2018
SELL
$114.49 - $139.98 $7.84 Million - $9.59 Million
-68,486 Reduced 44.13%
86,699 $11 Million
Q3 2017

Nov 09, 2017
BUY
$72.53 - $118.27 $1.97 Million - $3.21 Million
27,135 Added 21.19%
155,185 $18.2 Million
Q2 2017

Aug 11, 2017
BUY
N/A
128,050
128,050 $10.2 Million

Others Institutions Holding ALNY

# of Institutions
724
Shares Held
111M
Call Options Held
966K
Put Options Held
853K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $40B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email